본문 바로가기

Meta-Analysis of Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in Patients With Non ST-Segment Elevation Acute Coronary Syndrome and Multivessel Coronary Disease

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
AMERICAN JOURNAL OF CARDIOLOGY115(8) · pp.1027 · 2015
피인용
Web of Science 17
JCR IF
JCR 2014 3.276
ISSN
0002-9149

저자

  1. Jang, Jae-Sik제1저자인제대학교, Coll Med, Dept Cardiol, KO
  2. Jin, Han-Young인제대학교, Coll Med, Dept Cardiol, KO
  3. Seo, Jeong-Sook인제대학교, Coll Med, Dept Cardiol, KO
  4. Yang, Tae-Hyun인제대학교, Coll Med, Dept Cardiol, KO
  5. Kim, Dae-Kyeong인제대학교, Coll Med, Dept Cardiol, KO
  6. Kim, Dong-Soo인제대학교, Coll Med, Dept Cardiol, KO
  7. Cho, Kyoung-Im고신대학교, Med Ctr, Dept Cardiol, KO
  8. 김보현부산대학교, 의과대학, 의학과, KO
  9. 박용현부산대학교, 의과대학, 의학과, KO
  10. 제형곤부산대학교, 의과대학, 의학과, KO

초록

Even in the era of contemporary drug-eluting stents, it is not clear whether percutaneous coronary intervention (PCI) for nonculprit lesions can improve long-term outcomes in patients with non ST-segment elevation acute coronary syndrome (NSTE-ACS) with multivessel coronary disease. Relevant studies published through August 2014 were searched and identified in the electronic databases. Summary estimates were obtained using a randomeffects model. From 368 initial citations, 8 observational studies with 8,425 patients (3,227 multivessel and 5,198 culprit-only PCI) were included. Mean follow-up duration was 18 months. There were no significant differences in all-cause mortality (odds ratios [ORs] 0.85, 95% confidence interval [CI] 0.70 to 1.04) and myocardial infarction (OR 0.86, 95% CI 0.55 to 1.35). However, multivessel PCI was associated with a significantly lower rate of repeat revascularization (OR 0.75, 95% CI 0.56 to 1.00). Comparison of multivessel versus culprit-only PCI disclosed OR for major adverse cardiac events of 0.74(95% CI 0.57 to 0.97). In conclusion, multivessel PCI reduced repeat revascularization without significant benefits in terms of mortality or myocardial infarction at the long-term follow-up in patients with NSTE-ACS and multivessel coronary disease. Future randomized studies that examine the safety and efficacy of multivessel PCI in NSTE-ACS are warranted. (C) 2015 Elsevier Inc. All rights reserved.

키워드

ASSOCIATION TASK-FORCEMYOCARDIAL-INFARCTIONARTERY-DISEASEELUTING STENTPRACTICE GUIDELINESRANDOMIZED-TRIALUNSTABLE ANGINASINGLE-VESSELREVASCULARIZATIONMANAGEMENT

식별자

WoS UID
000353077700004